The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 10, 2018

Filed:

Oct. 19, 2016
Applicant:

Genesis Technologies Limited, Warrens, St. Michael, BB;

Inventors:

Jan-Eric Ahlfors, Laval, CA;

Rouwayda El-Ayoubi, Laval, CA;

Assignee:

GENESIS TECHNOLOGIES LIMITED, Warrens, St. Michael, BB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); C12N 5/0797 (2010.01); C12N 5/074 (2010.01); C12N 5/0775 (2010.01); C12N 5/077 (2010.01); C12N 5/0789 (2010.01);
U.S. Cl.
CPC ...
C12N 5/0623 (2013.01); C12N 5/0647 (2013.01); C12N 5/0656 (2013.01); C12N 5/0667 (2013.01); C12N 5/0668 (2013.01); C12N 5/0696 (2013.01); C12N 2501/06 (2013.01); C12N 2501/065 (2013.01); C12N 2501/11 (2013.01); C12N 2501/115 (2013.01); C12N 2501/13 (2013.01); C12N 2501/155 (2013.01); C12N 2501/16 (2013.01); C12N 2501/602 (2013.01); C12N 2501/604 (2013.01); C12N 2501/727 (2013.01); C12N 2501/998 (2013.01); C12N 2506/094 (2013.01); C12N 2506/11 (2013.01); C12N 2506/1307 (2013.01); C12N 2506/1384 (2013.01); C12N 2510/00 (2013.01);
Abstract

A method of obtaining a neural multipotent, unipotent or somatic cell, comprising: i) providing a cell of a first type which is not a neural multipotent, unipotent or somatic cell; ii) introducing into the cell of a first type an agent capable of remodeling the chromatin and/or DNA of the cell, wherein the agent capable of remodeling the chromatin and/or DNA is a histone acetylator, an inhibitor of histone deacetylation, a DNA demethylator, and/or a chemical inhibitor of DNA methylation; iii) increasing directly or indirectly the endogenous expression of at least one neural multipotent or unipotent gene regulator in the cell of a first type, to a level at which the gene regulator is capable of driving transformation of the cell of a first type into the neural multipotent, unipotent or somatic cell, wherein the gene regulator is Msi1, Ngn2, Sox2, Ascl1, Zic1 or a combination thereof; and iv) placing or maintaining the cell in a neural cell culture medium and maintaining intracellular levels of the reprogramming agent for a sufficient period of time to allow a neural multipotent, unipotent or somatic cell to be obtained.


Find Patent Forward Citations

Loading…